Cas 905858-49-3,{(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester

905858-49-3

Post Buying Request

Basic information

Product Name: {(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester
Synonyms: {(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester
CAS NO:905858-49-3
Molecular Formula:
Molecular Weight: 425.528
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: {(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: {(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester(905858-49-3)
EPA Substance Registry System: {(S)-1-[((S)-1-Carbamoyl-2-phenyl-ethylcarbamoyl)-methyl]-2-phenyl-ethyl}-carbamic acid tert-butyl ester(905858-49-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 905858-49-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

905858-49-3 Suppliers

Recommended suppliers

905858-49-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 905858-49-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,8,5 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 905858-49:
(8*9)+(7*0)+(6*5)+(5*8)+(4*5)+(3*8)+(2*4)+(1*9)=203
203 % 10 = 3
So 905858-49-3 is a valid CAS Registry Number.

905858-49-3Upstream product

905858-49-3Downstream Products

839730-17-5 (S)-3-Amino-N-((S)-1-carbamoyl-2-phenyl-ethyl)-4-phenyl-butyramide

905858-49-3Relevant academic research and scientific papers

Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds

Gilleron,Millet,Houssin,Wlodarczyk,Farce,Lemoine,Goossens,Chavatte,Pommery,Henichart

, p. 745 - 755 (2006)

Oncogenic Ras proteins whose activation is farnesylation by farnesyltransferase have been seen as important targets for novel anticancer drugs. Inhibitors of this enzyme have already been developed as potential anti-cancer drugs, particularly by rational

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 905858-49-3